Other News To Note
Tuesday, November 22, 2011
Dendreon Corp., of Seattle, said that under an updated coverage policy, the Centers for Medicare & Medicaid Services (CMS) will now cover the infusion costs associated with the administration of Provenge (sipuleucel-T).
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.